In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
Advocacy
Doctor standing in front of a rainbow flag
Out in Front: Scientists and Activists Call for Recognition of LGBT Cancer Risks

How does being lesbian, gay, bisexual, or transgender affect your risk of getting cancer? Good question.
Finding
Tumor mutation model
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
In the Lab
Pictured: Activated macrophage
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
In the Lab
scan of mouse blood vessel
Surprising Discovery Connects Rare Vascular Disease to Cancer Gene

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.
Seen are Scott Stuart, MSK Chair, Board of Trustees, and Selwyn M. Vickers, MD, FACS, President and CEO of MSK
A Message From MSK Leaders Selwyn M. Vickers and Scott Stuart

The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report.
Memorial Sloan Kettering physician-scientist Vinod Balachandran.
Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic

MSK researchers are making important inroads in understanding and treating pancreatic cancer.
Finding
Zsofia Stadler
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
Finding
A doctor examines a mole.
Don't Scratch That Mole? Scientists Are Learning More about Inflammation and Cancer

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.
Finding
Mike Philbin
How Telemedicine Reshaped Genetic Counseling during the COVID-19 Pandemic

A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received.